Company Filing History:
Years Active: 2025
Title: Innovations of Agostinho Carvalho in Inhaler Technology
Introduction
Agostinho Carvalho is an accomplished inventor based in Leiria, Portugal, known for his innovative contributions to inhaler technology. With a deep understanding of pharmaceuticals and engineering, Carvalho has developed a unique solution aimed at improving the administration of inhaled medications.
Latest Patents
Carvalho holds a patent for his invention titled "Large dose disposable inhaler and method of simple filling." This dry powder inhaler is designed for pulmonary or nasal use and features an inhaler body and a cartridge containing multiple compartments, each filled with a single dose of medication. The inhaler's design allows the cartridge to be securely attached to the body, enabling a controlled advancement and rotation to effectively deliver the medication. This innovation not only focuses on ease of use but also addresses cost efficiency in the manufacturing process, making it suitable for high-dosage delivery at a lower production cost.
Career Highlights
Currently, Agostinho Carvalho works with Hovione Technology Ltd., a company known for its advancements in pharmaceuticals and innovative inhalation technologies. His tenure at Hovione Technology Ltd. has allowed him to further his expertise and contribute to projects that aim to enhance the efficiency of drug delivery methods.
Collaborations
Throughout his career, Carvalho has collaborated closely with his coworker, Peter Villax. Their partnership has fostered a creative environment that encourages the development of cutting-edge solutions in inhaler technology. This collaboration has paved the way for innovative projects that address the needs of patients and healthcare providers alike.
Conclusion
Agostinho Carvalho's innovative spirit and dedication to improving inhaler technology through patentable inventions underscore his importance in the field. His work not only enhances patient experience but also optimizes manufacturing processes in the pharmaceutical industry. As he continues to develop new solutions, Carvalho's contributions will undoubtedly influence the future of inhalation therapy.